Art
J-GLOBAL ID:201402257860290440   Reference number:14A0304662

Guideline for economic evaluation of healthcare technologies in Japan

保健医療における費用対効果の評価方法と活用 医療経済評価研究における分析手法に関するガイドライン
Author (15):
Material:
Volume: 62  Issue:Page: 325-640  Publication year: Dec. 2013 
JST Material Number: F0799A  ISSN: 1347-6459  Document type: Article
Article type: 解説  Country of issue: Japan (JPN)  Language: JAPANESE (JA)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0304662&from=J-GLOBAL&jstjournalNo=F0799A") }}
JST classification (1):
JST classification
Category name(code) classified by JST.
Medical systems 
Reference (45):
  • Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
  • Hay JW, Smeeding J, Carroll NV, et al. Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report-Part I. Value Health. 2010;13:3-7.
  • Garrison LP, Jr., Mansley EC, Abbott TA, 3rd, Bresnahan BW, Hay JW, Smeeding J. Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report-Part II. Value Health. 2010;13:8-13.
  • NICE. Guide to the methods of technology appraisal 2013. London: The National Institute for Health and Care Excellence; 2013.
  • CADTH. Guidelines for the economic evaluation of health technologies. 3rd ed. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2006.
more...

Return to Previous Page